Literature DB >> 26555691

Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time?

Malte Rieken1, Alexander Bachmann, Shahrokh F Shariat.   

Abstract

PURPOSE OF REVIEW: Surgical techniques are an integral part of the urologist's armamentarium for the treatment of benign prostatic obstruction. Currently, several techniques are available. The purpose of the current review is to analyse the long-term outcomes of currently available techniques. RECENT
FINDINGS: Open prostatectomy shows a low long-term reoperation rate. Available evidence suggests that bipolar transurethral resection of the prostate (TURP) is an attractive alternative to monopolar TURP as both techniques lead to a long-lasting and comparable efficacy. For patients with a larger prostate volume, bipolar enucleation of the prostate appears as safe and effective alternative to open prostatectomy. Holmium laser enucleation of the prostate appears as a durable alternative to TURP and open prostatectomy with comparable long-term results. For photoselective vaporization of the prostate, differently powered models are available. Currently, only long-term data with lower powered 80 W laser are available, reporting reoperation rates higher than those reported from other surgical techniques. On the thulium laser, currently only one study reported 5-year results and despite encouraging results further confirmation seems necessary.
SUMMARY: Various surgical methods have proven to be safe and effective for the treatment of benign prostate obstruction and stand the test of time. The choice of the technique depends on prostate size, risk factors of the patient as well as expertise of the surgeon.

Entities:  

Mesh:

Year:  2016        PMID: 26555691     DOI: 10.1097/MOU.0000000000000244

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  6 in total

1.  Greenlight® users should move from photoselective vaporization to endoscopic enucleation in larger prostates.

Authors:  Benoit Peyronnet; Vincent Misrai; Tev Aho; Henry Woo; Thomas Herrmann; Fernando Gomez-Sancha
Journal:  World J Urol       Date:  2017-04-28       Impact factor: 4.226

2.  The Advantages of Transurethral Resection of the Prostate in Patients with an Elevated or Rising Prostate Specific Antigen, Mild or Moderate Lower Urinary Tract Symptoms, Bladder Outlet Obstruction and Negative Prostate Cancer Imaging or Prostate Biopsies: A Prospective Analysis in 105 Consecutive Patients.

Authors:  Evert Baten; Koenraad van Renterghem
Journal:  Curr Urol       Date:  2017-07-30

3.  Is loss of power output due to laser fiber degradation still an issue during prostate vaporization using the 180 W GreenLight XPS laser?

Authors:  Thomas Hermanns; Nico C Grossmann; Marian S Wettstein; Etienne X Keller; Christian D Fankhauser; Oliver Gross; Benedikt Kranzbühler; Martin Lüscher; Alexander H Meier; Tullio Sulser; Cédric Poyet
Journal:  World J Urol       Date:  2018-06-19       Impact factor: 4.226

4.  Green Light photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml.

Authors:  Jie Sun; An Shi; Zhen Tong; Chenfei Chi
Journal:  Lasers Med Sci       Date:  2018-04-28       Impact factor: 3.161

5.  Learning curves and perioperative outcomes after endoscopic enucleation of the prostate: a comparison between GreenLight 532-nm and holmium lasers.

Authors:  Benoit Peyronnet; Grégoire Robert; Vincent Comat; Morgan Rouprêt; Fernando Gomez-Sancha; Jean-Nicolas Cornu; Vincent Misrai
Journal:  World J Urol       Date:  2016-10-20       Impact factor: 4.226

6.  Prostate volume reduction following pure transurethral bipolar plasma vaporization and conventional transurethral resection of the prostate: a prospective investigation using transrectal 3D ultrasound volumetry.

Authors:  Benedikt Kranzbühler; Oliver Gross; Christian D Fankhauser; Marian S Wettstein; Nico C Grossmann; Lukas J Hefermehl; Matthias Zimmermann; Alexander Müller; Daniel Eberli; Tullio Sulser; Cédric Poyet; Thomas Hermanns
Journal:  World J Urol       Date:  2016-06-23       Impact factor: 4.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.